About: Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series
Creator	Zajkowska, Joanna Radmard, Sara Thakur, Kiran Boehme, Amelia Shapiro, Steven Willey, Joshua Bain, Jennifer Testai, Fernando Duran, Juan Epstein, Samantha Michalak, Andrew Roeder, Hannah Wilson, Tommy Aj, Michalak Duran, J Hj, Roeder Jm, Bain Jz, Willey Sd, Shapiro Se, Epstein Tj, Wilson Vargas, Alejandro
Source	Medline; PMC
abstract	Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily causes respiratory illness. However, neurological sequelae from novel coronavirus disease 2019 (COVID-19) can occur. Patients with neurological conditions may be at higher risk of developing worsening of their underlying problem. Here we document our initial experiences as neurologic consultants at a single center quaternary hospital at the epicenter of the COVID-19 pandemic. Methods: This was a retrospective case series of adult patients diagnosed with SARS-CoV-2 who required neurological evaluation in the form of a consultation or primary neurological care from March 13, 2020 to April 1, 2020. Results: Thirty-three patients (ages 17–88 years) with COVID-19 infection who required neurological or admission to a primary neurology team were included in this study. The encountered neurological problems associated with SARS-CoV-2 infection were encephalopathy (12 patients, 36.4%), seizure (9 patients, 27.2%), stroke (5 patients, 15.2%), recrudescence of prior neurological disease symptoms (4 patients, 12.1%), and neuromuscular (3 patients, 9.1%). The majority of patients who required evaluation by neurology had elevated inflammatory markers. Twenty-one (63.6%) patients were discharged from the hospital and 12 (36.4%) died from COVID-19 related complications. Conclusion: This small case series of our initial encounters with COVID-19 infection describes a range of neurological complications which are similar to presentations seen with other critical illnesses. COVID-19 infection did not change the overall management of neurological problems.
has issue date	2020-07-10(xsd:dateTime)
bibo:doi	10.3389/fneur.2020.00805
bibo:pmid	32754113
has license	cc-by
sha1sum (hex)	397dc2a414145ea8c759fbb513b3f276c3983e37
schema:url	https://doi.org/10.3389/fneur.2020.00805
resource representing a document's title	Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series
has PubMed Central identifier	PMC7365853
has PubMed identifier	32754113
schema:publication	Front Neurol
resource representing a document's body	covid:397dc2a414145ea8c759fbb513b3f276c3983e37#body_text
is schema:about of	named entity 'CUIMC' named entity 'encephalopathy' named entity 'neurological problems' named entity 'SAH' named entity 'CAD' named entity 'inflammatory markers' named entity 'medical history' named entity 'IL-6' named entity 'IVIG' named entity 'peripheral arterial disease' named entity 'diabetes mellitus' named entity 'COVID-19 infection' named entity 'coronary artery bypass grafting' named entity 'encephalopathy' named entity 'cardiovascular risk factors' named entity 'Immune suppression' named entity 'SARS-CoV-2' named entity 'intracerebral hemorrhage' named entity 'autoimmune encephalitis' named entity 'blood brain barrier' named entity 'Institutional Review Board' named entity 'Azithromycin' named entity 'protein' named entity 'Informed consent' named entity 'case-series study' named entity 'pg/mL' named entity 'neurology' named entity 'IV immunoglobulin' named entity 'intellectual disability' named entity 'immunodeficiency' named entity 'Case series' named entity 'infection' named entity 'toxicity' named entity 'brachial artery' named entity 'consciousness' named entity 'COVID' named entity 'seizure' named entity 'seizure' named entity 'neuronal degeneration' named entity 'COVID' named entity 'seizures' named entity 'intraventricular hemorrhage' named entity 'ferritin' named entity 'COVID' named entity 'central nervous' named entity 'primary care' named entity 'natalizumab' named entity 'outpatient setting' named entity 'right-sided weakness' named entity 'CSF' named entity 'multiple sclerosis' named entity 'symptomatic treatment' named entity 'Azithromycin' named entity 'Angiogram' named entity 'SARS-CoV-2' named entity 'MRI brain' named entity 'Systemic inflammation' named entity 'comorbidities' named entity 'IRB' named entity 'petechial hemorrhage'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software